山河药辅: 第六届董事会第六次会议决议公告

Core Viewpoint - The company held its sixth board meeting on July 31, 2025, where several key resolutions were passed, including the reappointment of the auditing firm and the signing of an investment agreement for a new project [1][2][3]. Group 1: Audit and Governance - The board approved the reappointment of Rongcheng Accounting Firm for the 2025 annual audit, with the management authorized to negotiate the audit fees based on various factors [1][2]. - The board proposed to increase the number of board members from 7 to 8, adding one employee representative director while maintaining the number of independent directors at 3 [3][4]. - The board also approved the formulation and revision of several corporate governance systems, which will be submitted for shareholder approval [4]. Group 2: Project Investment - The board agreed to sign an investment cooperation agreement with the Huainan Economic and Technological Development Zone Management Committee for a high-end auxiliary material manufacturing base project [2][3]. - This investment agreement will also require shareholder approval at the upcoming extraordinary general meeting [2][3]. Group 3: Shareholder Meeting - The board scheduled the 2025 first extraordinary general meeting for August 18, 2025, to review the resolutions passed during the board meeting [4].